Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
Clinical trial NCT01874054 · COMPLETED
Trial details
- NCT number
- NCT01874054
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.